Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
369
datasets available to search
ShareScore release 0.9.0
Dataset results
369 results for “adalimumab”
A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
ClinicalTrials.gov study NCT01162421. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effect of Two Methotrexate in Sync With the First Adalimumab to Prevent the Immunisation Anti Ada in Spondyloarthritis
ClinicalTrials.gov study NCT04360785. IPD Sharing: NO. Countries: 1. Publications: 0.
Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium
ClinicalTrials.gov study NCT01845818. IPD Sharing: NO. Countries: 0. Publications: 0.
Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab
ClinicalTrials.gov study NCT00650390. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)
ClinicalTrials.gov study NCT01870986. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
ClinicalTrials.gov study NCT00963313. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients
ClinicalTrials.gov study NCT02687828. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China
ClinicalTrials.gov study NCT02668640. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects
ClinicalTrials.gov study NCT02927353. IPD Sharing: NO. Countries: 1. Publications: 0.
Psoriatic Inflammation Markers Predictive of Response to Adalimumab
ClinicalTrials.gov study NCT03389984. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers
ClinicalTrials.gov study NCT01029613. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis
ClinicalTrials.gov study NCT02634541. IPD Sharing: NO. Countries: 1. Publications: 0.
Primary UVB-311nm and Adalimumab in Psoriasis Patients
ClinicalTrials.gov study NCT00638261. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
ClinicalTrials.gov study NCT02506179. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea
ClinicalTrials.gov study NCT01181570. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated
ClinicalTrials.gov study NCT05683054. IPD Sharing: NO. Countries: 1. Publications: 0.
Adalimumab-psoriasis and Small Bowel Lesions
ClinicalTrials.gov study NCT01556672. IPD Sharing: NO. Countries: 1. Publications: 0.
Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting
ClinicalTrials.gov study NCT05633771. IPD Sharing: NO. Countries: 2. Publications: 0.
Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum
ClinicalTrials.gov study NCT00690846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ADalimumab in Persistent Early Oligoarthrits Study (ADEOS)
ClinicalTrials.gov study NCT04154852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.